Sunday, September 20, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 2, 2026

Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus

View original at finance.yahoo.com
Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus Last week, the U.S. market performance was mixed, with gains from strong corporate earnings largely neutralized by slower growth expectations, rising inflation concerns and geopolitical tension…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Weekly jobless claims remained low at 212,000

    80% confidence

  • Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements

    80% confidence

  • Core PPI climbed 0.8% after gaining 0.6% in December

    80% confidence

  • Higher-than-expected PPI numbers suggest inflation may not be cooling as quickly as hoped

    80% confidence

  • The U.S. economy remains resilient, supported by strong corporate profits and a solid job market

    80% confidence

  • Producer Price Index rose 0.5% for January, exceeding the 0.3% consensus estimate

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com
Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus — Source | Via News | Via News